Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.59 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.42 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.42 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.42 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.42 |
| ▸ | DPP7 | Q9UHL4 | 8/20 | 0.41 |
| ▸ | DPP8 | Q6V1X1 | 4/20 | 0.41 |
| ▸ | DPP9 | Q86TI2 | 4/20 | 0.41 |
| ▸ | DPP4 | P27487 | 2/20 | 0.41 |
| ▸ | CPB2 | Q96IY4 | 3/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.38 |
| ▸ | FAP | Q12884 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4352729 | 1.00 | GSR (0.59) | GSRGNAI3GNAO1GNAI1RNPEP | |
| SCHEMBL16192990 | 1.00 | GSR (0.59) | GSRGNAI3GNAO1GNAI1RNPEP | |
| SCHEMBL14811921 | 0.98 | GSR (0.57) | GSRGNAI3GNAO1GNAI1RNPEP | |
| SCHEMBL1408948 | 0.93 | GSR (0.50) | GSRGNAI3GNAO1GNAI1RNPEP | |
| SCHEMBL1408946 | 0.93 | GSR (0.50) | GSRGNAI3GNAO1GNAI1RNPEP | |
| SCHEMBL20240364 | 0.89 | GSR (0.61) | GSRGNAI3GNAO1GNAI1RNPEP | |
| SCHEMBL1404247 | 0.89 | GSR (0.61) | GSRGNAI3GNAO1GNAI1RNPEP | |
| SCHEMBL344574 | 0.89 | GSR (0.61) | GSRGNAI3GNAO1GNAI1RNPEP | |
| SCHEMBL680614 | 0.87 | GSR (0.59) | GSRGNAI3GNAO1GNAI1RNPEP | |
| Hydrochloric Acid SCHEMBL3825519 | 0.87 | GSR (0.59) | GSRGNAI3GNAO1GNAI1RNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6285 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118599796-A | Lysine amine dehydrogenase mutant and application thereof in chiral amine compound synthesis | 山东大学 | 2024-09-06 | — | — | CN | claimed |
| CN-117986328-B | Cyclic peptide luminescent coupling molecule and preparation method and application thereof | 江西省转化医学研究院 | 2024-07-09 | — | — | CN | claimed |
| CN-116283916-B | Compound with Axl and c-Met kinase inhibition activity and preparation and application thereof | 中国科学院上海药物研究所 | 2024-06-11 | — | — | CN | claimed |
| EP-3277099-B9 | HIGH EFFICIENCY OXALATE-DEGRADING ENZYMES FOR DEGRADATION OF INSOLUBLE AND SOLUBLE OXALATE | OXIDIEN PHARMACEUTICALS LLC (US) | 2024-05-29 | — | — | EP | claimed |
| CN-118005710-A | Method for controlling double-protein coupling proportion based on cyclopeptide and application | 南昌大学 | 2024-05-10 | — | — | CN | claimed |
| CN-117986328-A | Cyclic peptide luminescent coupling molecule and preparation method and application thereof | 江西省转化医学研究院 | 2024-05-07 | — | — | CN | claimed |
| EP-3197501-B1 | BIOLOGICAL MATERIALS AND USES THEREOF | ANTIKOR BIOPHARMA LTD (GB) | 2024-04-10 | — | — | EP | claimed |
| WO-2024044674-A1 | DNA ORIGAMI VACCINES | OHIO STATE INNOVATION FOUNDATION (US) | 2024-02-29 | — | — | WO | claimed |
| WO-2024044663-A2 | PEPTIDE AND NUCLEIC ACID METHODS TO MODULATE DELIVERY OF NUCLEIC ACID STRUCTURES, POLYPEPTIDES, AND THEIR CARGOES | OHIO STATE INNOVATION FOUNDATION (US) | 2024-02-29 | — | — | WO | claimed |
| EP-4297581-A1 | COMPOSITIONS FOR PREPARING ANIMAL-FREE EGG-LIKE PRODUCTS | Clara Foods Co. (US) | 2024-01-03 | — | — | EP | claimed |
| EP-0553281-A1 | PREPARATION AND CHARACTERIZATION OF LIPOSOMAL FORMULATIONS OF TUMOR NECROSIS FACTOR. | UNIV TEXAS (US) | 1993-08-04 | — | — | EP | claimed |
| EP-0253190-B1 | PARTIALLY RETRO-INVERTED TUFTSIN ANALOGUES, METHOD FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ENIRICERCHE S.p.A. (IT) | 1992-12-30 | — | — | EP | claimed |
| EP-0231883-B1 | HYBRID PLASMINOGEN ACTIVATOR-LIKE POLYPEPTIDE | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1992-09-02 | — | — | EP | claimed |
| US-5116947-A | PROCESS FOR THE PREPARATION OF RETRO-INVERSO PEPTIDES AND NEW INTERMEDIATES THEREOF | SCLAVO S.P.A. (IT) | 1992-05-26 | — | — | US | claimed |
| WO-1992006995-A1 | PREPARATION AND CHARACTERIZATION OF LIPOSOMAL FORMULATIONS OF TUMOR NECROSIS FACTOR | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1992-04-30 | — | — | WO | claimed |
| US-4997913-A | Antibody-spacer-drug | ONCOGEN (US) | 1991-03-05 | — | — | US | claimed |
| EP-0375040-A2 | Process for the preparation of retro-inverso peptides and new intermediates thereof | SCLAVO S.p.A. (IT) | 1990-06-27 | — | — | EP | claimed |
| EP-0253202-A2 | Novel immunoconjugates and methods for their use in tumor therapy | ONCOGEN (US) | 1988-01-20 | — | — | EP | claimed |
| US-4360646-A | Preparation of lysine based macromolecular highly branched homogeneous compound | ALLIED CORPORATION (US) | 1982-11-23 | — | — | US | claimed |
| US-4356170-A | OXIDATION OF VICINAL HYDROXY GROUPS ON POLYSACCHARIDE, REDUCTIVE AMINATION WITH PROTEIN | CANADIAN PATENTS & DEVELOPMENT LTD. (CA) | 1982-10-26 | — | — | US | claimed |